• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombus (2101)
Event Date 12/11/2019
Event Type  Injury  
Manufacturer Narrative
Image review: two images were returned for evaluation.The 1st image appears to be dilated proximal segment of a gsv.The image does not clearly show thrombus given the quality.The 2nd image shows what appears to be non-occlusive thrombus at the saphenofemoral junction.The non-occlusive thrombus may have slightly extended into the common femoral vein.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician use venaseal occluding device during procedure to treat 2 segments in the great saphenous vein and anterior accessory great saphenous vein (gsv and aagsv).Local anesthesia was used.The lumen was flushed prior to use.The ifu was followed during preparation, procedure and post procedure.A guide wire was used for the insertion of the catheter.The procedure was finished per ifu.It was reported that during the initial follow up scan 2 days post procedure clot/thrombus was noted.The area that was treated was reported to be very swollen and the patient was unable to bend the leg that was treated.Mild erythema and warmth to the right leg noted.The physician prescribed a prednisone dose pack, oral pills, for the patient's treatment.Patient on xarelto also.The patient's condition has been reported to have been resolved a week after and the follow up scan revealed no deep vein thrombus left.There was no further patient injury reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9691579
MDR Text Key182473603
Report Number9612164-2020-00654
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient Weight101
-
-